Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/s0272-6386(12)80948-6 http://scihub22266oqcxt.onion/10.1016/s0272-6386(12)80948-6 1585928!ä!1585928 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=1585928&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Kidney+Dis 1992 ; 19 (5): 420-6 Nephropedia Template TP {{tp|p=1585928|t=1992. Diltiazem enhances potassium disposal in subjects with end-stage renal disease |pdf=|usr=}}{{1585928}} gab.com Text Diltiazem enhances potassium disposal in subjects with end-stage renal disease JO: Am J Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=1585928 #FOAvip Seven subjects with end-stage renal disease (ESRD) who were anuric and dialysis-dependent were studied during a 28-hour interdialytic period to assess changes in plasma potassium. Plasma potassium, glucose, magnesium, aldosterone, and cortisol were measured every 4 hours. Eight normal subjects were similarly treated. Subjects with ESRD had a progressive increase in plasma potassium, in contrast to normal subjects who exhibited a characteristic diurnal variation. In ESRD, diltiazem significantly reduced the rate of increase in plasma potassium compared with placebo and resulted in a significantly lower net increase in potassium over the entire 28-hour period. Diltiazem did not affect plasma potassium in normal subjects. Diltiazem did not affect plasma aldosterone, cortisol, glucose, or magnesium. In conclusion, diltiazem reduced the rate of increase of plasma potassium during a 28-hour interdialytic period. Twit Text FOAVip Diltiazem enhances potassium disposal in subjects with end-stage renal disease ????Am J Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=1585928 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=1585928 #FOAvip English Wikipedia <ref>{{Cite pmid|1585928}}</ref> Diltiazem enhances potassium disposal in subjects with end-stage renal disease #MMPMID1585928 Solomon R; Dubey A Am J Kidney Dis 1992[May]; 19 (5): 420-6 PMID1585928show ga Seven subjects with end-stage renal disease (ESRD) who were anuric and dialysis-dependent were studied during a 28-hour interdialytic period to assess changes in plasma potassium. Plasma potassium, glucose, magnesium, aldosterone, and cortisol were measured every 4 hours. Eight normal subjects were similarly treated. Subjects with ESRD had a progressive increase in plasma potassium, in contrast to normal subjects who exhibited a characteristic diurnal variation. In ESRD, diltiazem significantly reduced the rate of increase in plasma potassium compared with placebo and resulted in a significantly lower net increase in potassium over the entire 28-hour period. Diltiazem did not affect plasma potassium in normal subjects. Diltiazem did not affect plasma aldosterone, cortisol, glucose, or magnesium. In conclusion, diltiazem reduced the rate of increase of plasma potassium during a 28-hour interdialytic period. |Adolescent[MESH] |Adult[MESH] |Aldosterone/blood[MESH] |Blood Glucose/analysis[MESH] |Circadian Rhythm[MESH] |Diltiazem/pharmacology/*therapeutic use[MESH] |Female[MESH] |Humans[MESH] |Hydrocortisone/blood[MESH] |Kidney Failure, Chronic/blood/*drug therapy/metabolism[MESH] |Male[MESH] |Middle Aged[MESH] |Potassium Channels/drug effects[MESH] |Potassium/blood/*metabolism[MESH]Diltiazem enhances potassium disposal in subjects with end-stage renal(epmc).pdf DeepDyve Pubget Overpricing